Involvement of insulin-like growth factor binding protein-3 in the retinoic acid receptor-α-mediated inhibition of hepatocellular carcinoma cell proliferation

Cancer Letters

Volumn 151, Issue 1, 2000, Pages 63-70

  Murakami, Koji ^a,b   Matsuura, Tomokazu ^c   Hasumura, Satoshi ^c   Nagamori, Seishi ^c   Yamada, Yuji ^b   Saiki, Ikuo ^a  

^a Inst Nat Med   (Japan)

^b Hanno Res Ctr Taiho P   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; Insulin like growth factor binding protein 3; Retinoic acid receptor

Indexed keywords

RETINOIC ACID RECEPTOR; SOMATOMEDIN BINDING PROTEIN 3;

ARTICLE; CARCINOMA CELL; CELL PROLIFERATION; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIGAND BINDING; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOATES; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LIVER NEOPLASMS; MICE; MICE, NUDE; RECEPTORS, RETINOIC ACID; RETINOIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAHYDRONAPHTHALENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0034599989     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00410-3     Document Type: Article

References (43)

1. Mangelsdorf D.J., Umesono K., Evans R.M. The Retinoid Receptors. Sporn M.B., Roberts A.B., Goodman D.S. The Retinoids: Biology, Chemistry, and Medicine. 2nd Edition :1994;319-349.
2. Petkovich M., Brand N.J., Krust A., Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature. 330:1987;444-450.
3. Brand N., Petkovich M., Krust A., Chambon P., de The H., Marchio A., Tiollais P., Dejean A. Identification of a second human retinoic acid receptor. Nature. 332:1988;850-853.
4. Krust A., Kastner P., Petkovich M., Zelent A., Chambon P. A third human retinoic acid receptor, hRAR-gamma. Proc. Natl. Acad. Sci. USA. 86:1989;5310-5314.
5. Mangelsdorf D.J., Ong E.S., Dyck J.A., Evans R.M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 345:1990;224-229.
6. Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J.Y., Staub A., Garnier J.M., Mader S., Chambon P. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 68:1992;377-395.
7. Heyman R.A., Mangelsdorf D.J., Dyck J.A., Stein R.B., Eichele G., Evans R.M., Thaller C. 9-cis Retinoic acid is a high affinity ligand for the retinoid X receptor. Cell. 68:1992;397-406.
8. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;940-954.
9. Tamura K., Kagechika H., Hashimoto Y., Shudo K., Ohsugi K., Ide H. Synthetic retinoids, retinobenzoic acids, Am80, Am580 and Ch55 regulate morphogenesis in chick limb bud. Cell Differ. 32:1990;17-26.
10. Hashimoto Y., Kagechika H., Kawachi E., Hukuzawa H., Saito G., Shudo K. Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. J. Cancer Res. Clin. Oncol. 121:1995;696-698.
11. Breitman T., Selonick S.E., Collins S.J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA. 77:1980;2936-2940.
12. Sun S.Y., Yue P., Dawson M.I., Shroot B., Michel S., Lamph W.W., Heyman R.A., Teng M., Chandraratna R.A., Shudo K., Hong W.K., Lotan R. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res. 57:1997;4931-4939.
13. Ueda H., Takenawa T., Millan J.C., Gesell M.S., Brandes D. The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells. Cancer. 46:1990;2203-2209.
14. Shalinsky D.R., Biscoff E.D., Gregory M.L., Gottardis J.S., Hayes J.S., Lamph W.W., Heyman R.A., Shirley M.A., Cooke T.A., Davies P.J.A., Thomazy V. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice. Cancer Res. 55:1995;3183-3191.
15. Brembeck F.H., Kaiser A., Detjen K., Hotz H., Foitzik T., Buhr H.J., Riecken E.O., Rosewicz S. Retinoic acid receptor alpha mediates growth inhibition by retinoids in rat pancreatic carcinoma DSL-6A/C1 cells. Br. J. Cancer. 78:1998;1288-1295.
16. Stewart L.V., Thomas M.L. Retinoids differentially regulate the proliferation of colon cancer cell lines. Exp. Cell Res. 233:1997;321-329.
17. Kim D.G., Jo B.H., You K.R., Ahn D.S. Apoptosis induced by retinoic acid in Hep3B cells in vitro. Cancer Lett. 107:1996;149-159.
18. Hung M.E., Ye Y.C., Chen S.R., Chai J.R., Lu J.X., Zhoa L., Gu L.J., Wang Z.Y. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:1998;567-572.
19. Ohno R., Yoshida H., Fukutani H., Naoe T., Ohshima T., Kyo T., Endoh N., Fujimoto T., Kobayashi T., Hiraoka A., Mizoguchi H., Kodera Y., Suzuki H., Hirano M., Akiyama H., Aoki N., Shindo H., Yokomaku S. Multi-institutional study of all-trans-retinoic acid as a differentiation therapy of refractory acute promyelocytic leukemia. Leukaemia Study Group of the Ministry of Health and Welfare. Leukemia. 7:1993;1722-1727.
20. Degos L., Dombret H., Chomienne C., Daniel M.T., Miclea J.M., Chastang C., Castaigne S., Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood. 85:1995;2643-2653.
21. Muindi J., Frankel S.R., Miller W.H. Jr., Jakubowski A., Scheinberg D.A., Young C.W., Dmitrovsky E., Warrell R.P. Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid 'resistance' in patients with acute promyelocytic leukemia. Blood. 79:1992;299-303.
22. Adamson P.C., Boylan J.F., Balis F.M., Murphy R.F., Godwin K.A., Gudas L.J., Poplack D.G. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res. 53:1993;472-476.
23. Tobita T., Takeshita A., Kitamura K., Ohnishi K., Yanagi M., Hiraoka A., Karasuno T., Takeuchi M., Miyawaki S., Ueda R., Naoe T., Ohno R. Treatment with a new synthetic retinoid. Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood. 90:1997;967-973.
24. Picard E., Seguin C., Monhoven N., Rochette-Egly C., Siat J., Borrelly J., Martinet Y., Martinet N., Vignaud J.M. Expression of retinoid receptor genes and proteins in non-small-cell lung cancer. J. Natl. Cancer Inst. 91:1999;1059-1066.
25. Han Q.X., Allegretto E.A., Shao Z.M., Kute T.E., Ordonez J., Aisner S.C., Rishi A.K., Fontana J.A. Elevated expression of retinoic acid receptor-alpha (RAR alpha) in estrogen-receptor-positive breast carcinomas as detected by immunohistochemistry. Diagn. Mol. Pathol. 6:1997;42-48.
26. Sever C.E., Locker J. Expression of retinoic acid alpha and beta receptor genes in liver and hepatocellular carcinoma. Mol. Carcinog. 4:1991;138-144.
27. Han G.R., Dohi D.F., Lee H.Y., Rajah R., Walsh G.L., Hong W.K., Cohen P., Kurie J.M. All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoic acid receptor-alpha-dependent signaling pathway. J. Biol. Chem. 272:1997;13711-13716.
28. Oh Y. IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine. 7:1997;111-113.
29. Gucev Z.S., Oh Y., Kelley K.M., Labarta J.I., Vorwerk P., Rosenfeld R.G. Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocellular carcinoma cells. Endocrinology. 138:1997;1464-1470.
30. Shaarawy M., Fikry M.A., Massoud B.A., Lotfy S. Insulin-like growth factor binding protein-3: a novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis. J. Clin. Endocrinol. Metab. 83:1998;3316-3319.
31. Sohda T., Yun K., Iwata K., Soejima H., Okumura M. Increased expression of insulin-like growth factor 2 in hepatocellular carcinoma is primarily regulated at the transcriptional level. Lab. Invest. 75:1996;307-311.
32. Aihara T., Noguchi S., Miyoshi Y., Nakano H., Sasaki Y., Nakamura Y., Monden M., Imaoka S. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver. Hepatology. 28:1998;86-89.
33. Li Y., Hashimoto Y., Agadir A., Kagechika H., Zhang X.K. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells. J. Biol. Chem. 274:1999;15360-15366.
34. Murakami K., Matsuura T., Sano M., Hashimoto A., Yonekura K., Sakukawa R., Yamada Y., Saiki I. 4-[3,5-Bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) inhibits the intrahepatic spread of hepatocellular carcinoma and prolongs the life-span of tumor-bearing animals. Clin. Exp. Metastasis. 16:1998;633-643.
35. McArdle B.H. The significance of differences between means. A simulation study. Comp. Biochem. Physiol. 87:1987;979-982.
36. Hilton J.F. The appropriateness of the Wilcoxon test in ordinal data. Stat. Med. 30:1996;631-645.
37. Hochberg Y., Tamhane A.C. Multivariate t-Distribution. Hochberg Y., Tamhane A.C. Multiple Comparison Procedures. 1987;374-375 Wiley, New York.
38. Ludbrook J. Comparing methods of measurements. Clin. Exp. Pharmacol. Physiol. 24:1997;193-203.
39. Love J.M., Gudas L.J. Vitamin A, differentiation and cancer. Curr. Opin. Cell Biol. 6:1994;825-831.
40. Sakukawa R., Murakami K., Ikeda T., Yamada Y., Saiki I. Effect of 4-[3,5-bis(trimethylsilyl)benzamido] benzoic acid (TAC-101) on the liver metastasis of colon 26-L5 carcinoma cells. Oncol. Res. 10:1998;287-293.
41. Murakami K., Wierzba K., Sano M., Shibata J., Yonekura K., Hashimoto A., Sato K., Yamada Y. TAC-101, a benzoic acid derivative, inhibits liver metastasis of human gastrointestinal cancer and prolongs the life-span. Clin. Exp. Metastasis. 16:1998;323-331.
42. Meyskens F.L. Jr., Jacobson J., Nguyen B., Weiss G.R., Gandara D.R., MacDonald J.S. Phase II trial of oral beta-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157). Invest. New Drugs. 16:1998;171-173.
43. Standeven A.M., Teng M., Chandraratna A.S. Lack of involvement of retinoic acid receptor alpha in retinoid-induced skin irritation in hairless mice. Toxicol. Lett. 92:1997;231-240.